- About
- Events
- Resource Center
Archives
Major Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Major Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)
Major depressive disorder affects more than 260 million people worldwide.1 The reported prevalence of depression in patients with chronic kidney disease ranges from 20-65%.2 This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology.
1. World Health Organization. Fact Sheet on Depression. (2012) https://www.who.int/health-topics/depression#tab=tab_1
2. Teles F et al. Clinics (Sao Paulo). 2014 ;69(3):198-202.
Featuring
Chris Bojrab, MD
PsychiatristTeam Psychiatrist for the Indiana Pacers*
Chris Bojrab, MD has served as President of Indiana Health Group since 2003. Dr. Bojrab is the team psychiatrist for the Indiana Pacers, and serves as the psychiatric consultant to the Indianapolis Colts and the Indianapolis Indians.
He is active in organized medicine on a state and national level, having served as President of the Young Physician Section of the Indiana State Medical Association as well as holding offices in the American Medical Association and the American Psychiatric Association. Dr. Bojrab graduated from Wabash College and then attended Indiana University School of Medicine, where he received his M.D. He completed a four-year residency in psychiatry at the Indiana University Medical Center, where he served as Chief Resident.
Rima Kang, MD
Assistant Professor of Clinical MedicineDivision of Nephrology, The Ohio State University, Columbus, Ohio*
Upon joining faculty at Ohio State, Dr Kang has become the lead nephrologist in cystic kidney disease care and was instrumental in developing a specialty clinic at Ohio State with an emphasis in ADPKD and CKD. Dr Kang continues to advocate for improved patient care and is an active member in multiple associations and committees, including the National Kidney Foundation (NKF), the Internal Medicine Quality and Patient Safety Committee, and the Internal Medicine Diversity and Inclusion Committee. Dr Kang received her medical degree from Northeast Ohio Medical University, and completed her residency in Internal Medicine at the University of Cincinnati Medical Center in Cincinnati, Ohio. Dr Kang then went on to complete a distinguished fellowship in Nephrology at The Ohio State University Wexner Medical Center.
*Drs Bojrab and Kang are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).
Registration
Related Events
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - Events
